News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


FDA TO FACILITATE ACCESS TO UNAPPROVED DRUGS


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

This sounds like a great program. We have been helping patients get access to experimental treatments for a while and it takes a lot of time on our part, the doctor’s part and the drug companies' part.  I hope that this will smooth things over.

If anyone tries it, please let me know how it works out!

 


Posted on: 12/21/2018

FDA TO FACILITATE ACCESS TO UNAPPROVED DRUGS

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740